Single staged bilateral total hip replacement and its outcomes: A cross-sectional study

Area of Science:

• Orthopedic Surgery
• Arthroplasty
• Hip Disorders

Background:

• Bilateral hip osteoarthritis affects a significant portion of the population, with many requiring total hip replacement (THR).
• Approximately 25% of individuals undergoing THR may need bilateral replacement, highlighting the need for efficient surgical strategies.

Purpose of the Study:

• To evaluate the clinical outcomes and cost-effectiveness of single-stage bilateral total hip replacement (B/L THR).
• To assess the safety and efficacy of B/L THR in a tertiary care hospital setting.

Main Methods:

• A retrospective observational study analyzed data from patients who underwent single-stage B/L THR between January 2018 and July 2023.
• Clinical outcomes, complication rates, and re-admission rates were assessed for 75 patients.

Main Results:

• The study included 75 patients with a mean age of 36 years.
• A low complication rate of 4.0% was observed, including acute coronary syndrome, acetabular fracture, and paralytic ileus.
• The re-admission rate was also 4%, indicating favorable patient recovery.

Conclusions:

• Single-stage B/L THR is a safe and cost-effective procedure for managing bilateral hip disorders.
• Careful patient selection (e.g., low American Society of Anesthesiologist score) contributed to favorable outcomes, even in obese patients.
• Prophylactic measures effectively managed systemic complications like deep vein thrombosis and pulmonary embolism, supporting early ambulation and restoration of daily activities.